N Ishida Selected Research

N Ishida Research Topics

Disease

3	Neoplasms (Cancer) 07/2008 - 06/2001
2	Obesity 02/2015 - 08/2006
2	Osteoporosis 08/2010 - 04/2001
2	Hypertrophy 01/2009 - 08/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2006 - 07/2006
2	Infarction (Infarctions) 07/2006 - 06/2001
2	Hyperplasia 12/2001 - 02/2001
2	Ascites 06/2001 - 03/2001
2	Stomach Neoplasms (Stomach Cancer) 06/2001 - 03/2001
2	Carcinoma (Carcinomatosis) 06/2001 - 03/2001
1	Hyperglycemia 01/2017
1	Prediabetic State (Prediabetes) 02/2015
1	Glucose Intolerance 02/2015
1	Insulin Resistance 02/2015
1	Type 2 Diabetes Mellitus (MODY) 02/2015
1	Bone Resorption 08/2010
1	Pain (Aches) 01/2010
1	Herpes Simplex 01/2010
1	Herpes Zoster 01/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2009
1	Skin Neoplasms (Skin Cancer) 04/2009
1	Residual Neoplasm 02/2009
1	Actinic Keratosis 02/2009
1	Body Weight (Weight, Body) 01/2009
1	Thrombosis (Thrombus) 07/2006
1	Atherosclerosis 11/2001
1	Blister (Bulla) 10/2001
1	Pulmonary Embolism 10/2001
1	Lung Diseases (Lung Disease) 10/2001
1	Pathologic Constriction (Stenosis) 08/2001
1	Colonic Neoplasms (Colon Cancer) 06/2001
1	Necrosis 06/2001
1	Colorectal Neoplasms (Colorectal Cancer) 06/2001
1	Coronary Occlusion 06/2001
1	Sleep Wake Disorders 04/2001
1	Hereditary Corneal Dystrophies 11/2000
1	Corneal dystrophy Avellino type 11/2000
1	Malaria 08/2000
1	Hearing Loss (Hearing Impairment) 08/2000
1	Pathologic Dilatation (Ectasia) 08/2000
1	Aortitis 08/2000
1	Aortic Dissection 08/2000
1	Seizures (Absence Seizure) 08/2000
1	Heart Failure 08/2000
1	Hypothyroidism 08/2000

Drug/Important Bio-Agent (IBA)

3	AcidsIBA 04/2009 - 08/2000
3	Messenger RNA (mRNA)IBA 08/2006 - 08/2000
2	DNA (Deoxyribonucleic Acid)IBA 01/2010 - 04/2001
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2009 - 02/2009
2	Plasminogen Activators (Plasminogen Activator)IBA 08/2006 - 07/2006
2	Plasminogen Activator Inhibitor 1IBA 08/2006 - 07/2006
2	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2001 - 02/2001
2	Complementary DNA (cDNA)IBA 06/2001 - 02/2000
1	Singlet OxygenIBA 02/2015
1	Glucose (Dextrose)FDA LinkGeneric 02/2015
1	Free RadicalsIBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	hydroxyoctadecadienoic acidIBA 02/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2010
1	1,4-dihydroxy-2-naphthoic acidIBA 08/2010
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2010
1	Antiviral Agents (Antivirals)IBA 01/2010
1	Viral DNAIBA 01/2010
1	Etretinate FDA Link 04/2009
1	Vitamin A (Retinol)FDA LinkGeneric 04/2009
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2009
1	Imatinib Mesylate (Gleevec)FDA Link 07/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2008
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 11/2001
1	Oxygen (Dioxygen)IBA 10/2001
1	Superoxide DismutaseIBA 06/2001
1	CarbohydratesIBA 06/2001
1	AntigensIBA 06/2001
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2001
1	Sialyl Lewis X AntigenIBA 06/2001
1	alpha-thujaplicinIBA 06/2001
1	UDP-galactose translocatorIBA 06/2001
1	polyethylene glycol-superoxide dismutaseIBA 06/2001
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 06/2001
1	E-SelectinIBA 06/2001
1	Thomsen-Friedenreich antigenIBA 06/2001
1	Vitamin K FDA Link 04/2001
1	2-hydroxy-5-isopropyl- 2,4,6-cycloheptatrienoneIBA 03/2001
1	beta-dolabrinIBA 03/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2000
1	SugarsIBA 08/2000
1	Biological ProductsIBA 08/2000
1	AMPA Receptors (AMPA Receptor)IBA 08/2000
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 08/2000
1	2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA 08/2000
1	Aquaporin 5IBA 08/2000
1	LipopolysaccharidesIBA 08/2000

Therapy/Procedure

2	Photochemotherapy (Photodynamic Therapy) 04/2009 - 02/2009
2	Intravenous Infusions 12/2001 - 08/2000
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2001 - 08/2000
1	Transplantation 01/2017
1	Ligation 01/2009
1	Catheters 12/2001
1	Microspheres (Microsphere) 06/2001
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 08/2000